Advertisement

Interleukin 1

Release from LPS-Stimulated Mononuclear Phagocytes
  • Lawrence B. Lachman

Abstract

Interleukin 1 (IL 1), previously known as lymphocyte-activating factor (LAF), is key mediator of macrophage function. Macrophages release IL 1 following stimulation with bacterial endotoxin (Gery and Waks-man, 1972), substances that possess adjuvant properties (Oppenheim et al., 1980), or phagocytic stimuli (Rosenwasser et al., 1979). IL 1 can completely replace macrophages in some in vitro immunological assay systems (Maizel et al., 1981) and greatly reduce the number of macrophages required in other systems (Rosenberg and Lipsky, 1981). IL 1 probably replaces the soluble activating factor released by macrophages but cannot replace the macrophage function of antigen or lectin presentation (Rosenberg and Lipsky, 1981). IL 1 may also regulate nonimmunological responses that involve macrophages. Specifically, IL 1 may be identical to the fever-producing substance endogenous pyrogen (Murphy et al., 1980; Rosenwasser et al., 1979), and appears to stimulate prostaglandin and collagenase release from synovial cells (Mizel et al., 1981) and to release acute-phase reactants (Selinger et al., 1980).

Keywords

Thymidine Incorporation Macrophage Cell Line Normal Human Serum Muramyl Dipeptide Mouse Thymocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bernheim, H. A., Block, L. H., Francis, L., and Atkins, E., 1980, Release of endogenous pyrogen-activating factor from concanavalin A-stimulated human lymphocytes, J. Exp. Med. 152:1811.PubMedCrossRefGoogle Scholar
  2. Diamanstein, T., Klos, M., and Reiman, J., 1981, Studies on T-lymphocyte activation. I. Is competence induction in thymocytes by phorbol myristate acetate an accessory cell-independent event?, Immunology 43:183.Google Scholar
  3. English, D., and Anderson, B. R., 1974, Single-step separation of red blood cells, granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque, J. Immunol. Methods 5:249.PubMedCrossRefGoogle Scholar
  4. Farrar, J. J., Simon, P. L., Farrar, W. L., Koopman, W. J., and Fullar-Bonar, J., 1979, Role of mitogenic factor, lymphocyte-activating factor and immune interferon in the induction of humoral and cell-mediated immunity, Ann. N.Y. Acad. Sci. 332:303.PubMedCrossRefGoogle Scholar
  5. Fumarola, D., and Jirillo, E., 1979, Endotoxin contamination of some commercial preparations used in experimental research, in: Biomedical Applications of the Horseshoe Crab, pp. 379–385, Liss, New York.Google Scholar
  6. Gery, I., and Waksman, B. H., 1972, Potentiation of T-lymphocyte response to mitogens. II. The cellular source of potentiating mediators, J. Exp. Med. 136:143.PubMedCrossRefGoogle Scholar
  7. Hanson, D. F., Murphy, P. A., and Windle, B. E., 1980, Failure of rabbit neutrophils to secrete endogenous pyrogen when stimulated with staphylococci, J. Exp. Med. 151: 1360.PubMedCrossRefGoogle Scholar
  8. Kampschmidt, R. F., and Upchurch, H. F., 1980, Neutrophil release after injection of endotoxin or leukocytic endogenous mediator into rats, J. Reticuloendothelial Soc. 28:191.Google Scholar
  9. Lachman, L. B., and Metzgar, R. S., 1980a, Purification and characterization of human lymphocyte activating factor, in: Biochemical Characterization of Lymphokines (A. L. deWeck, F. Kristensen, and M. Landy, eds.), pp. 397–398, 405–409, Academic Press, New York.Google Scholar
  10. Lachman, L. B., and Metzgar, R. S., 1980b, Characterization of high and low molecular weight lymphocyte activating factor (interleukin 1) from P388D1 and J774.1 mouse macrophage cell lines, J. Reticuloendothelial Soc. 27:621.Google Scholar
  11. Lachman, L. B., Hacker, M. P., Blyden, G. T., and Handschumacher, R. E., 1977, Preparation of lymphocyte activating factor from continuous murine macrophage cell lines, Cell. Immunol. 34:416.PubMedCrossRefGoogle Scholar
  12. Lachman, L. B., Moore, J. O., and Metzgar, R. S., 1979, Preparation and characterization of lymphocyte activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells, Cell. Immunol. 41:199.CrossRefGoogle Scholar
  13. Lachman, L. B., Page, S. O., and Metzgar, R. S., 1980, Purification of human interleukin, I, J. Supramol. Struct. 13:457.PubMedCrossRefGoogle Scholar
  14. Lachman, L. B., George, F. W., IV, and Metzgar, R. S., 1981, Human interleukin 1 and 2: Purification and characterization, in: Lymphokines and Thymic Factors (A. L. Goldstein and M. A. Chirigos, eds.), pp. 21–32, Raven Press, New York.Google Scholar
  15. Larrick, J. W., Fisher, D. G., Anderson, S. J., and Koren, H. S., 1980, Characterization of a human macrophage-like cell line stimulated in vitro: A model of macrophage functions, J. Immunol. 125:6.PubMedGoogle Scholar
  16. Larsson, E.-L., and Coutinho, A., 1980, Mechanism of T cell activation. I. A screening of “step one” ligands, Eur. J. Immunol. 10:93.PubMedCrossRefGoogle Scholar
  17. Levin, N., Hatcher, V. B., and Lazarus, G. S., 1976, Proteinases of human epidermis: A possible mechanism for polymorphonuclear leukocyte Chemotaxis, Biochim. Biophys. Acta 452:458.Google Scholar
  18. Maizel, A. L., Mehta, S. R., Ford, R. J., and Lachman, L. B., 1981, Effect of interleukin 1 on human thymocytes and purified human T cells, J. Exp. Med. 153:470.PubMedCrossRefGoogle Scholar
  19. Männel, D. N., Farrar, J. J., and Mergenhagen, S. E., 1980, Separation of a serum-derived tumoricidal factor from a helper factor for plaque-forming cells, J. Immunol. 124: 1106.PubMedGoogle Scholar
  20. Mizel, S. B., and Mizel, D., 1981, Purification to apparent homogeneity of murine interleukin 1, J. Immunol. 126:834.PubMedGoogle Scholar
  21. Mizel, S. B., Rosenstreich, D. L., and Oppenheim, J. J., Phorbol myristic acetate stimulates LAF production by the macrophage cell line P388D1, Cell. Immunol. 40:230.Google Scholar
  22. Mizel, S. B., Dayer, J. M., Krane, S. M., and Mergenhagen, S. E., 1981, Stimulation or rhuematoid synovial cell collegenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1), Proc. Xatl. Acad. Sci. USA 78:2474.CrossRefGoogle Scholar
  23. Moore, R. N., Oppenheim, J. J., Farrar, J. J., Carter, C. S., Jr., Waheed, A., and Shadduck, R. K., 1980, Production of lymphocyte-activating factor (interleukin 1) by macrophages activated with colony-stimulating factors, J. Immunol. 125:1302.PubMedGoogle Scholar
  24. Morgan, D. A., Ruscetti, F. W., and Gallo, R. C., 1976, Selective in vitro growth of T lymphocytes from normal human bone marrows, Science 193:1007.PubMedCrossRefGoogle Scholar
  25. Morrison, D. C., and Jacobs, D. M., 1976, Inhibition of lipopolysaccharide-initiated activation of serum complement by polymyxin B, Infect. Immun. 13:298.PubMedGoogle Scholar
  26. Murphy, P. A., Simon, P. L., and Willoughby, W. F., 1980, Endogenous pyrogens made by rabbit alveolar macrophages, J. Immunol. 124:2498.PubMedGoogle Scholar
  27. Oakley, B. R., Kirsch, D. R., and Morris, N. R., 1980, A simple ultra-sensitive silver stain for detecting proteins in Polyacrylamide gels, Anal. Biochem. 105:361.PubMedCrossRefGoogle Scholar
  28. Oppenheim, J. J., Togawa, A., Chedid, L., and Mizel, S., 1980, Components of mycobacteria and muramyl dipeptide with adjuvant activity induce lymphocyte activating factor, Cell. Immunol. 50:71.PubMedCrossRefGoogle Scholar
  29. Otterness, I. G., Lachman, L. B., and Bliven, M. L., 1981, Effects of levamisole on the proliferation of thymic lymphocyte subpopulations, Immunopharmacology 3:61.PubMedCrossRefGoogle Scholar
  30. Rosenberg, A. S., and Lipsky, P. E., 1981, The role of monocytes in pokeweed mitogen-stimulated human B cell activation: Separate requirements for intact monocytes and a soluble monocyte factor, J. Immunol. 126:1341.PubMedGoogle Scholar
  31. Rosenstreich, D. L., and Mizel, S. B., 1979, Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate, J. Immunol. 123:1749.PubMedGoogle Scholar
  32. Rosenwasser, L. J., Dinarello, C. A., and Rosenthal, A. S., 1979, Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen, J. Exp. Med. 150:709.PubMedCrossRefGoogle Scholar
  33. Selinger, M. J., McAdams, K. P., Kaplan, M. M., Sipe, J. D., Vogel, S. N., and Rosenstreich, D. L., 1980, Monokine induced synthesis of serum amyloid A protein by hepatocytes, Sature (London) 285:498.CrossRefGoogle Scholar
  34. Smith, K. A., Lachman, L. B., Oppenheim, J. J., and Favata, M. F., 1980, The functional relationship of the intcrleukins, J. Exp. Med. 151:1551.PubMedCrossRefGoogle Scholar
  35. Togowa, A., Oppenheim, J. J., and Mizel, S. B., 1979, Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: Biochemical relationship of high and low molecular weight forms of LAY, J. Immunol. 122:2112.Google Scholar
  36. Wood, D. D., and Cameron, P. M., 1978, The relationship between bacterial endotoxin and human B cell-activating factor, J. Immunol. 121:53.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1983

Authors and Affiliations

  • Lawrence B. Lachman
    • 1
  1. 1.Immunex CorporationSeattleUSA

Personalised recommendations